Adrenal incidentalomas

Endocrine Surgery

Volumn , Issue , 2003, Pages 411-427

  Aron, David C ^a   Kievit, Job ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747032380     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (86)

1. Aron DC. Endocrine incidentalomas. Endocrinol Metab Clin North Am 2002; 29:1-238.
2. Lau J, Balk E, Rothberg M, Ioannidid JPA, DeVine D, Chew P, Kupelnick B, Miller K. Management of Clinically Inapparent Adrenal Mass. AHRQ Publication No. 02-E014. Rockville, MD: Agency for Healthcare Research and Quality. Evidence Report/Technology Assessment, Number 56.
3. NIH Consensus Panel. NIH State of the Science Conference on the Management of the Clinically Inapparent Adrenal Mass, 2002.
4. Koch CA, Pacak K, Chrousos GP. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 2002; 87:5367-5384.
5. Aron DC. The adrenal incidentaloma: disease of modern technology and public health problem. Rev Endocr Metab Disord 2001; 2:335-342.
6. Reincke M. Subclinical Cushing’s syndrome. Endocrinol Metab Clin North Am 2000; 29:43-56.
7. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W. Preclinical Cushing’s syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 1992; 75:826-832.
8. Terzolo M, Osella G, Ali A, Borreta G, Cesario F, Paccotti P, Angeli A. Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 1998; 48:89-97.
9. Angeli A, Osella G, Ali A, Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 1997; 47:279-283.
10. Barzon L, Boscaro M. Diagnosis and management of adrenal incidentalomas. J Urol 2000; 163:398-407.
11. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G. Sub-clinical Cushing’s syndrome in patients with adrenal in-cidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000; 85:1440-1448.
12. Tauchmanova L, Rossi R, Nuzzo V, del Puente A, Es-posito-del Puente A, Pizzi C, Fonderico F, Lupoli G, Lombardi G. Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol 2001; 145:241-247.
13. Torlontano M, Chiodini I, Pileri M, Guglielmi G, Cam-misa M, Modoni S, Carnevale V, Trischitta V, Scillitani A. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hy-percortisolism. J Clin Endocrinol Metab 1999; 84:23812385.
14. Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf) 2001; 54:797-804.
15. Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002; 87:998-1003.
16. Chiodini I, Tauchmanova L, Torlontano M, Battista C, Guglielmi G, Cammisa M, Colao A, Carnevale V, Rossi R, Di Lembo S, Trischitta V, Scillitani A. Bone involvement in eugonadal male patients with adrenal incidental-oma an dsubclinical hypercortisolism. J Clin Endocrinol Metab 2002; 87:5491-5494.
17. Francucci CM, Pantanetti P, Garrapa GG, Massi F, Arnaldi G, Mantero F. Bone metabolism and mass in women with Cushing’s syndrome and adrenal incidentaloma. Clin Endocrinol (Oxf) 2002; 57:587-593.
18. Tauchmanova L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri E-A, Fazio S, Lonbardi G. Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002; 87:4872-4878.
19. Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Ale-vizaki C, Thalassinos N. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin Endocrinol 1998;49:165-171.
20. Barzon L, Scaroni C, Sonino N, Fallo F, Gregianin M, Macri C, Boscaro M. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 1998; 83:55-62.
21. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999; 84:520-526.
22. Barzon L, Fallo F, Sonino N, Boscaro M. Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002; 146:61-66.
23. Young WF Jr. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 2000; 29:159-185, 10.
24. Boscaro M, Fallo F, Barzon L, et al. Adrenocortical carcinoma: epidemiology and natural history. Minerva Endocrinol 1995; 20:89-94.
25. Icard P, Chapuis Y, Andreis M, et al. Adrenocortical carcinoma in surgically treated patients: a retrspective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992; 112:972-979.
26. Copeland PM. The incidentally discovered adrenal mass. Ann Intern Med 1983; 98:940-945.
27. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000; 85:637-644.
28. Terzolo M, Ali A, Osella G, Mazza E. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 1997; 132:914-919.
29. Bardet S, Rohmer V, Murat A, Guillemot C, Marechaud R, Chupin M, Lecomte P, Simon D, Delemer B, Schneebelli S, Beutter D, Jacquin V, Peltier P, Charbon-nel B. 1311-6 Beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin Endocrinol (Oxf) 1996; 44:587-596.
30. Valli N, Catargi B, Ronci N, Vergnot V, Leccia F, Ferriere JM, Chene G, Grenier N, Laurent F, Tabarin A. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 2001; 144:401-408.
31. Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlum-berger M, Plouin PF, Luton JP, Le Bouc Y. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res 2001; 61:6762-6767.
32. Boulle N, Baudin E, Gicquel C, Logie A, Bertherat J, Penfomis A, Bertagna X, Luton JP, Schlumberger M, Le Bouc Y. Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors. Eur J Endocrinol 2002; 144:29-36.
33. Kolomecki K, Stepien H, Bartos M, Kuzdak K. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours. Endocr Regul 2001; 35:9-16.
34. Dunnick NR, Korobkin M. Imaging of adrenal in-cidentalomas: current status. AJR Am J Roentgenol 2002; 179:559-568.
35. Suzuki Y, Sasagawa, Suzuki H, Izumi T, Kaneko H, Nakada T. The role of ultrasonography in the detection of adrenal masses: comparison with computed tomography and magnetic resonance imaging. Int Urol Nephrol 2001; 32:303-306.
36. Fontana D, Porpiglia F, Destefanis P, Fiori C, Ali A, Terzolo M, Osella G, Angeli A. What is the role of ultrasonography in the follow-up of adrenal incidentalo-mas? The Gruppo Piemontese Incidentalomi Surrenalici. Urology 1999; 54:612-616.
37. Lumachi F, Zucchetta P, Marzola MC, Bui F, Casarru-bea G, Angelini F, Favia G. Usefulness of CT scan, MRI and radiocholesterol scintigraphy for adrenal imaging in Cushing’s syndrome. Nucl Med Commun 2002; 23:469-473.
38. Kievit J, Haak HR. Diagnosis and treatment of adrenal incidentaloma. A cost-effectiveness analysis. Endocrinol Metab Clin North Am 2000; 29:-699.
39. Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR, Raghupathi KI. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002; 222:629-633.
40. Mesurolle B, Ariche-Cohen M, Tardivon A, Gilles R, Couanet D, Vanel D. Retrospective analysis of 44 adrenal puncture biopsies under x-ray computed tomographic guidance. J Radiol 1996; 77:17-21.
41. Heaston DK, Handel DB, Ashton PR, Korobkin M. Narrow gauge needle aspiration of solid adrenal masses. AJR Am J Roentgenol 1982; 138:1143-1148.
42. Montali G, Solbiati L, Bossi MC, De Pra L, Di Donna A, Ravetto C. Sonographically guided fine-needle aspiration biopsy of adrenal masses. AJR Am J Roentgenol 1984; 143:1081-1084.
43. van Erkel AR, van Gils AP, Lequin M, Kruitwagen C, Bloem JL, Falke TH. CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J Com-put Assist Tomogr 1994; 18:432-438.
44. van Gils AP, Falke TH, van Erkel AR, Arndt JW, Sandler MP, van der Mey AG, Hoogma RP. MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiographics 1991; 11:37-57.
45. Varghese JC, Hahn PF, Papanicolaou N, Mayo-Smith WW, Gaa JA, Lee MJ. MR differentiation of phaeo-chromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times. Clin Radiol 1997; 52:603-606.
46. Kurtaran A, Traub T, Shapiro B. Scintigraphic imaging of the adrenal glands. Eur J Radiol 2002; 41:123130.
47. Francis IR, Smid A, Gross MD, Shapiro B, Naylor B, Glazer GM. Adrenal masses in oncologic patients: functional and morphologic evaluation. Radiology 1988; 166: 353-356.
48. Gross MD, Shapiro B, Shreve P. Radionuclide imaging of the adrenal cortex. Q J Nucl Med 1999; 43:224-232.
49. Kao CH, Liao SQ, Wang SJ, Lin MS, Hsu CY, Lin WY. I-131 NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism. Gaoxiong Yi Xue Ke Xue Za Zhi 1992; 8:213-218.
50. Kloos RT, Gross MD, Shapiro B, Francis IR, Korobkin M, Thompson NW. Diagnostic dilemma of small incidentally discovered adrenal masses: role for 1311-6beta-iodomethyl-norcholesterol scintigraphy. World J Surg 1997; 21:36-40.
51. Pauker SG, Kopelman RI. Trapped by an incidental finding. N Engl J Med 1992; 326:40-43.
52. Harisinghani MG, Maher MM, Hahn PF, Gervais DA, Jhaveri K, Varghese J, Mueller PR. Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol 2002; 57:898-901.
53. Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990; 323:1401-1405.
54. Young WF Jr. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endo Metab Clin North Am 2000; 29:159-185.
55. Siren J, Tervahartiala P, Sivula A, Haapiainen R. Natural course of adrenal incidentalomas: seven-year follow-up study. World J Surg 2000; 24:579-582.
56. Gotoh M, Ono Y, Hattori R, Kinukawa T, Ohshima S. Laparoscopic adrenalectomy for pheochromocytoma: morbidity compared with adrenalectomy for tumors of other pathology. J Endourol 2002; 16:245-249.
57. Kercher KW, Park A, Matthews BD, Rolband G, Sing RF, Heniford BT. Laparoscopic adrenalectomy for pheochromocytoma. Surg Endosc 2002; 16:100-102.
58. Orchard T, Grant CS, van Heerden JA, Weaver A. Pheochromocytoma—continuing evolution of surgical therapy. Surgery 1993; 114:1153-1158.
59. ReMine WH, Chong GC, van Heerden JA, Sheps SG, Harrison EG Jr. Current management of pheochromo-cytoma. Ann Surg 1974; 179:740-748.
60. Smith CD, Weber CJ, Amerson JR. Laparoscopic adrenalectomy: new gold standard. World J Surg 1999; 23: 389-396.
61. Neumann K, Langer R. Imaging methods in diagnosis of pheochromocytoma. Zentralbl Chir 1997; 122:438-442.
62. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287:1427-1434.
63. Lenders JW, Pacak K, Eisenhofer G. New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines. Ann NY Acad Sci 2002; 970:29-40.
64. Mantero F, Masini AM, Opocher G, Giovagnetti M, Arnaldi G. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. Horm Res 1997; 47:284-289.
65. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W. Preclinical Cushing’s syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 1992; 75:826-832.
66. Terzolo M, Osella G, Ali A, Borretta G, Cesario F, Paccotti P, Angeli A. Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 1998; 48:89-97.
67. Gill IS, Soble JJ, Sung GT, Winfield HN, Bravo EL, Novick AC. Needlescopic adrenalectomy—the initial series: comparison with conventional laparoscopic adrenalectomy. Urology 1998; 52:180-186.
68. Gill IS. The case of laparoscopic adrenalectomy. J Urol 2001; 166:429-436.
69. Henry JF, Defechereux T, Gramatica L, Raffaelli M. Should laparoscopic approach be proposed for large and/or potentially malignant adrenal tumors? Langen-becks Arch Surg 1999; 384:366-369.
70. Henry JF, Defechereux T, Raffaelli M, Lubrano D, Gramatica L. Complications of laparoscopic adrenalectomy: results of 169 consecutive procedures. World J Surg 2000; 24:1342-1346.
71. Henry JF. Minimally invasive adrenal surgery. Best Pract Res Clin Endocrinol Metab 2001; 15:149-160.
72. Ortega J, Sala C, Garcia S, Lledo S. Cost-effectiveness of laparoscopic vs open adrenalectomy: small savings in an expensive process. J Laparoendosc Adv Surg Tech A 2002; 12:1-5.
73. Schell SR, Talamini MA, Udelsman R. Laparoscopic adrenalectomy for nonmalignant disease: improved safety, morbidity, and cost-effectiveness. Surg Endosc 1999; 13:30-34.
74. Valeri A, Borrelli A, Presenti L, Lucchese M, Manca G, Tonelli P, Bergamini C, Borrelli D, Palli M, Saieva C. The influence of new technologies on laparoscopic adrenalectomy: our personal experience with 91 patients. Surg Endosc 2002; 16:1274-1279.
75. Hsu TH, Gill IS. Bilateral laparoscopic adrenalectomy: retroperitoneal and transperitoneal approaches. Urology 2002; 59:184-189.
76. Naya Y, Nagata M, Ichikawa T, Amakasu M, Omura M, Nishikawa T, Yamaguchi K, Ito H. Laparoscopic adrenalectomy: comparison of transperitoneal and retroperitoneal approaches. BJU Int 2002; 90:199-204.
77. Nagesser SK, Kievit J, Hermans J, Krans HM, van de Velde CJ. The surgical approach to the adrenal gland: a comparison of the retroperitoneal and the transabdominal routes in 326 operations on 284 patients. Jpn J Clin Oncol 2000; 30:68-74.
78. Hartgrink HH, Roelfsema F, Tollenaar RA, Hiddema PA, Pijl ME, van de Velde CJ. Primary pheochromocytoma extending into the right atrium: report of a case and review of the literature. Eur J Surg Oncol 2001; 27:115-119.
79. Jockenhovel F, Kuck W, Hauffa B, Reinhardt W, Benker G, Lederbogen S, Olbricht T, Reinwein D. Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas). J Endocrinol Invest 1992; 15:331-337.
80. Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, Migdalska B, Jeske W, Makowska A, Snochowska H. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 1997; 46:29-37.
81. Grossrubatscher E, Vignati F, Possa M, Lohi P. The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation. J Endocrinol Invest 2001; 24:846-855.
82. Libe R, Dall’Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 2002; 147: 489-494.
83. Best MA, Slavin LP, Aron DC. To regionalize or not to regionalize: that is the question. Part II. Volume-out-come relationships-endocrine disorders and their treatment. Endocrinologist 2000; 10:265-269.
84. Slavin LP, Best MA, Aron DC. To regionalize or not to regionalize: that is the question. Part I. Volume-outcome relationships—conceptual framework. Endocrinologist 2000; 10:205-210.
85. Fahlenkamp D, Rassweiler J, Fornara P, Freda T, Loening SA. Complications of laparoscopic procedures in urology: experience with 2,407 procedures at 4 German centers. J Urology 2002; 162:770.
86. Catarci M, Zaraca F, Mulieri G, Di Paola M, Monte-murro L, Filippoussis P, Greco E, Gossetti F, Carboni M. Surgical technique and results of 1006 consecutive cases of open laparoscopy. Chirurg Ital 2002; 51:151-158.